| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.072 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.06 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.077 | 0.7 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |